The first stop for professional medicines advice

Service advice

13 results

RelevanceNewest firstOldest firstTitle
Applied filters

Managing risks associated with the introduction of the Comirnaty vaccine for children 5 to 11 years old

21 January 2022Characteristics of Pfizer's Comirnaty vaccines for adults/adolescents and children differ. Teams must understand the differences to ensure safety.

Supply of vaccines under Mutual Aid

30 November 2021Considerations to note when seeking to transfer COVID-19 vaccinations from one provider to another

Institutional Readiness for Management of COVID-19 Vaccine Moderna in Trusts

23 March 2021Must read guidance for Chief Pharmacists and others in Trusts on the COVID-19 Vaccine Moderna

COVID-19 Vaccine Pfizer-BioNTech Handling and Preparation Video

28 January 2021A video produced by Pfizer showing the correct handling and preparation of the COVID-19 Vaccine Pfizer-BioNTech

Clinical prioritisation: using theory to optimise practice

20 January 2021Learn about different tools used across hospital pharmacy services in the UK and understand some of the barriers and enablers to patient prioritisation

Facilitating Pharmaceutical support to PCN Designated Sites for COVID-19 vaccinations

1 January 2021A set of principles underpin good pharmaceutical expertise for the vaccination programme; these are independent of the vaccine brand.

Institutional Readiness for management of Vaxzevria Vaccine in Trusts

31 December 2020Must read guidance for Chief Pharmacists and others in Trusts on the Vaxzevria Vaccine.

Institutional Readiness for managing both Comirnaty vaccines in Trusts

24 December 2020Must read guidance for Chief Pharmacists and others in Trusts on the COVID-19 Vaccine Pfizer-BioNTech.

Model NHS COVID-19 Vaccine handling and management policy 2020-21 for Trusts and Vaccination Centres

17 December 2020A model policy to enable organisation to implement good governance in the safe and secure handling and management of COVID-19 vaccines.

DS 21/75 Prescription Charges for Drugs Given to Patients in Clinical Trials (Department of Health and Social Security, 1975)

2 April 2019In 2019, this remains the only known documented government guidance to the NHS on the subject.